The IV Equipment Market is increasingly influenced by smart technologies designed to improve medication accuracy, patient monitoring, and healthcare workflow efficiency. Market Research Future estimates that the market will grow from USD 24.88 billion in 2025 to USD 34.0 billion by 2035 at a CAGR of 3.17%.

Smart infusion pumps are among the most significant technological developments in the industry. These systems can incorporate dose-error reduction software, automated alerts, connectivity, and advanced monitoring features. Such capabilities help healthcare professionals manage intravenous medication delivery more efficiently while supporting patient safety.

The increasing adoption of connected healthcare technologies is encouraging manufacturers to integrate IV equipment with hospital information systems and pharmacy automation platforms. This interoperability can streamline medication management and provide clinicians with better access to treatment information.

The market is also being influenced by stronger regulatory and infection-control requirements. Healthcare providers require equipment that meets rigorous safety and performance standards. Manufacturers are therefore focusing on safer catheter technologies, improved infusion systems, and products designed to reduce infection and medication-related risks.

IV catheters account for approximately 58.4% of the product market, making them the leading product category. Meanwhile, IV infusion pumps are positioned as a rapidly expanding category because healthcare providers increasingly seek automated solutions for precise fluid and drug administration.

Oncology remains the leading application segment, accounting for around 34.6% of the market. Intravenous chemotherapy and supportive therapies create substantial demand for reliable infusion equipment. Cardiology is also emerging as an important growth area as cardiovascular disease prevalence increases and treatment technologies advance.

Direct sales continue to dominate distribution, representing approximately 61.5% of the market in 2024. Healthcare facilities often prefer direct procurement for specialized medical equipment because it provides access to technical support, product expertise, and after-sales services. Online sales, however, are emerging as a faster-growing channel as healthcare purchasing becomes increasingly digital.

The continued development of smart, connected, and automated IV technologies is expected to shape the competitive landscape and create new opportunities through 2035.